Efficient traffic of cytotoxic T lymphocytes (CTLs) to metastatic sites in melanoma patients correlates with the expression of C-X-C Motif Chemokine Ligand 9 (CXCL9) and CXCL10 which are CXCR3 ligands. This evidence concerns the gene CXCL9 and melanoma.